Illumina Launches BioInsight Platform for Genomic and Multiomic Research
The platform combines analysis tools, purpose-built AI and curated biological data. It also includes a DRAGEN update.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
The platform combines analysis tools, purpose-built AI and curated biological data. It also includes a DRAGEN update.
The company describes BioInsight as its first unified software environment for genomic and multiomic research.
On Thursday, Illumina (NASDAQ: ILMN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Illumina reported strong Q2 2026 performance with revenue gr